| |
| |
|
| Insider
Information: |
Kapoor John N |
| Relationship: |
10% Owner |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
3,900,456 |
|
|
Indirect Shares
|
35,715,585 |
|
|
| Direct
Value |
$15,117 |
|
|
|
Indirect Value
|
$832,493 |
|
|
| Total
Shares |
39,616,041 |
|
|
| Total
Value |
$847,610 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cordex Pharma Inc |
CDXP |
Director, 10% Owner |
|
0 |
2004-08-30 |
1,408,049 |
Premium* |
|
|
Electric Motors Corporation |
EMCO |
Director |
2005-02-24 |
0 |
2006-07-31 |
3,305,173 |
Premium* |
|
|
Introgen Therapeutics Inc |
INGNQ |
Director |
2007-05-30 |
3,354,995 |
2005-04-11 |
0 |
Premium* |
|
|
Akorn Inc |
AKRX |
Director, 10% Owner |
2017-05-04 |
513,479 |
2017-05-04 |
30,946,075 |
Premium* |
|
|
Insys Therapeutics, Inc. |
INSY |
10% Owner |
2017-08-11 |
31,982 |
2018-02-27 |
56,288 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKRX |
Akorn Inc |
Director |
– • • |
2014-04-10 |
4 |
OE |
$1.11 |
$8,171,004 |
I/I |
7,192,313 |
31,082,237 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
President & CEO |
• • • |
2015-11-11 |
4 |
B |
$25.46 |
$255,221 |
I/I |
10,000 |
42,359,610 |
2.64 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
President & CEO |
• • • |
2015-11-12 |
4 |
B |
$25.18 |
$265,830 |
I/I |
10,000 |
42,369,610 |
2.64 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
President & CEO |
• • • |
2015-11-17 |
4 |
B |
$29.38 |
$147,493 |
I/I |
5,000 |
42,374,610 |
2.64 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
President & CEO |
• • • |
2016-05-11 |
4 |
B |
$12.94 |
$517,708 |
I/I |
40,000 |
42,414,610 |
2.64 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
President & CEO |
• • • |
2016-05-12 |
4 |
B |
$12.41 |
$124,119 |
I/I |
10,000 |
42,424,610 |
2.64 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
President & CEO |
• • • |
2016-08-12 |
4 |
B |
$18.57 |
$105,853 |
I/I |
5,700 |
42,430,310 |
2.64 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • • |
2017-08-11 |
4 |
B |
$8.93 |
$156,338 |
I/I |
17,500 |
42,447,810 |
2.25 |
- |
|
58 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
